Literature DB >> 27544586

Protection against henipaviruses in swine requires both, cell-mediated and humoral immune response.

Brad S Pickering1, John M Hardham2, Greg Smith3, Eva T Weingartl4, Paul J Dominowski2, Dennis L Foss2, Duncan Mwangi2, Christopher C Broder5, James A Roth6, Hana M Weingartl7.   

Abstract

Hendra virus (HeV) and Nipah virus (NiV) are members of the genus Henipavirus, within the family Paramyxoviridae. Nipah virus has caused outbreaks of human disease in Bangladesh, Malaysia, Singapore, India and Philippines, in addition to a large outbreak in swine in Malaysia in 1998/1999. Recently, NiV was suspected to be a causative agent of an outbreak in horses in 2014 in the Philippines, while HeV has caused multiple human and equine outbreaks in Australia since 1994. A swine vaccine able to prevent shedding of infectious virus is of veterinary and human health importance, and correlates of protection against henipavirus infection in swine need to be better understood. In the present study, three groups of animals were employed. Pigs vaccinated with adjuvanted recombinant soluble HeV G protein (sGHEV) and challenged with HeV, developed antibody levels considered to be protective prior to the challenge (titers of 320). However, activation of the cell-mediated immune response was not detected, and the animals were only partially protected against challenge with 5×10(5) PFU of HeV per animal. In the second group, cross-neutralizing antibody levels against NiV in the sGHEV vaccinated animals did not reach protective levels, and with no activation of cellular immune memory, these animals were not protected against NiV. Only pigs orally infected with 5×10(4) PFU of NiV per animal were protected against nasal challenge with 5×10(5) PFU of NiV per animal. This group of pigs developed protective antibody levels, as well as cell-mediated immune memory. Peripheral blood mononuclear cells restimulated with UV-inactivated NiV upregulated IFN-gamma, IL-10 and the CD25 activation marker on CD4(+)CD8(+) T memory helper cells and to lesser extent on CD4(-)CD8(+) T cells. In conclusion, both humoral and cellular immune responses were required for protection of swine against henipaviruses. Crown
Copyright © 2016. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell-mediated immune response; Hendra virus; Neutralizing antibody; Nipah virus; Swine

Mesh:

Substances:

Year:  2016        PMID: 27544586      PMCID: PMC6161494          DOI: 10.1016/j.vaccine.2016.08.028

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  40 in total

Review 1.  Once a killer, always a killer: from cytotoxic T cell to memory cell.

Authors:  Leo Lefrançois; Joshua J Obar
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  Immunology. Asymmetry and immune memory.

Authors:  Dan R Littman; Harinder Singh
Journal:  Science       Date:  2007-03-23       Impact factor: 47.728

3.  A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge.

Authors:  Katharine N Bossart; Barry Rockx; Friederike Feldmann; Doug Brining; Dana Scott; Rachel LaCasse; Joan B Geisbert; Yan-Ru Feng; Yee-Peng Chan; Andrew C Hickey; Christopher C Broder; Heinz Feldmann; Thomas W Geisbert
Journal:  Sci Transl Med       Date:  2012-08-08       Impact factor: 17.956

Review 4.  Henipaviruses in their natural animal hosts.

Authors:  D J Middleton; H M Weingartl
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

5.  A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge.

Authors:  Jackie Pallister; Deborah Middleton; Lin-Fa Wang; Reuben Klein; Jessica Haining; Rachel Robinson; Manabu Yamada; John White; Jean Payne; Yan-Ru Feng; Yee-Peng Chan; Christopher C Broder
Journal:  Vaccine       Date:  2011-07-01       Impact factor: 3.641

Review 6.  Molecular virology of the henipaviruses.

Authors:  Paul A Rota; Michael K Lo
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

7.  Experimental Nipah virus infection in pigs and cats.

Authors:  D J Middleton; H A Westbury; C J Morrissy; B M van der Heide; G M Russell; M A Braun; A D Hyatt
Journal:  J Comp Pathol       Date:  2002 Feb-Apr       Impact factor: 1.311

Review 8.  Epidemiology of henipavirus disease in humans.

Authors:  Stephen P Luby; Emily S Gurley
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

9.  A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection.

Authors:  Katharine N Bossart; Zhongyu Zhu; Deborah Middleton; Jessica Klippel; Gary Crameri; John Bingham; Jennifer A McEachern; Diane Green; Timothy J Hancock; Yee-Peng Chan; Andrew C Hickey; Dimiter S Dimitrov; Lin-Fa Wang; Christopher C Broder
Journal:  PLoS Pathog       Date:  2009-10-30       Impact factor: 6.823

10.  Outbreak of henipavirus infection, Philippines, 2014.

Authors:  Paola Katrina G Ching; Vikki Carr de los Reyes; Maria Nemia Sucaldito; Enrique Tayag; Alah Baby Columna-Vingno; Fedelino F Malbas; Gilbert C Bolo; James J Sejvar; Debbie Eagles; Geoffrey Playford; Erica Dueger; Yoshihiro Kaku; Shigeru Morikawa; Makoto Kuroda; Glenn A Marsh; Sam McCullough; A Ruth Foxwell
Journal:  Emerg Infect Dis       Date:  2015-02       Impact factor: 6.883

View more
  14 in total

Review 1.  The Immunobiology of Nipah Virus.

Authors:  Yvonne Jing Mei Liew; Puteri Ainaa S Ibrahim; Hui Ming Ong; Chee Ning Chong; Chong Tin Tan; Jie Ping Schee; Raúl Gómez Román; Neil George Cherian; Won Fen Wong; Li-Yen Chang
Journal:  Microorganisms       Date:  2022-06-06

2.  Indirect ELISA based on Hendra and Nipah virus proteins for the detection of henipavirus specific antibodies in pigs.

Authors:  Kerstin Fischer; Sandra Diederich; Greg Smith; Sven Reiche; Vinicius Pinho Dos Reis; Eileen Stroh; Martin H Groschup; Hana M Weingartl; Anne Balkema-Buschmann
Journal:  PLoS One       Date:  2018-04-30       Impact factor: 3.240

3.  Human Paramyxovirus Infections Induce T Cells That Cross-React with Zoonotic Henipaviruses.

Authors:  Rory D de Vries; Alwin de Jong; R Joyce Verburgh; Lucie Sauerhering; Gijsbert P van Nierop; Robert S van Binnendijk; Albert D M E Osterhaus; Andrea Maisner; Marion P G Koopmans; Rik L de Swart
Journal:  mBio       Date:  2020-07-07       Impact factor: 7.867

4.  Pathogenicity of Nipah henipavirus Bangladesh in a swine host.

Authors:  S B Kasloff; A Leung; B S Pickering; G Smith; E Moffat; B Collignon; C Embury-Hyatt; D Kobasa; H M Weingartl
Journal:  Sci Rep       Date:  2019-03-26       Impact factor: 4.379

Review 5.  Vaccine Development for Nipah Virus Infection in Pigs.

Authors:  Rebecca K McLean; Simon P Graham
Journal:  Front Vet Sci       Date:  2019-02-04

6.  Bovine Herpesvirus-4-Vectored Delivery of Nipah Virus Glycoproteins Enhances T Cell Immunogenicity in Pigs.

Authors:  Miriam Pedrera; Francesca Macchi; Rebecca K McLean; Valentina Franceschi; Nazia Thakur; Luca Russo; Lobna Medfai; Shawn Todd; Elma Z Tchilian; Jean-Christophe Audonnet; Keith Chappell; Ariel Isaacs; Daniel Watterson; Paul R Young; Glenn A Marsh; Dalan Bailey; Simon P Graham; Gaetano Donofrio
Journal:  Vaccines (Basel)       Date:  2020-03-02

7.  Fc-Based Recombinant Henipavirus Vaccines Elicit Broad Neutralizing Antibody Responses in Mice.

Authors:  Yaohui Li; Ruihua Li; Meirong Wang; Yujiao Liu; Ying Yin; Xiaodong Zai; Xiaohong Song; Yi Chen; Junjie Xu; Wei Chen
Journal:  Viruses       Date:  2020-04-23       Impact factor: 5.048

8.  A Soluble Version of Nipah Virus Glycoprotein G Delivered by Vaccinia Virus MVA Activates Specific CD8 and CD4 T Cells in Mice.

Authors:  Georgia Kalodimou; Svenja Veit; Sylvia Jany; Ulrich Kalinke; Christopher C Broder; Gerd Sutter; Asisa Volz
Journal:  Viruses       Date:  2019-12-24       Impact factor: 5.048

9.  Vaccines to Emerging Viruses: Nipah and Hendra.

Authors:  Moushimi Amaya; Christopher C Broder
Journal:  Annu Rev Virol       Date:  2020-09-29       Impact factor: 10.431

Review 10.  Recent advances in the understanding of Nipah virus immunopathogenesis and anti-viral approaches.

Authors:  Rodolphe Pelissier; Mathieu Iampietro; Branka Horvat
Journal:  F1000Res       Date:  2019-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.